(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-21 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 2757420
Date | Daily Closing Price | Open | High | Low | Volume |
21 Thu Nov 2024 | 45.70 | 45.85 | 46.12 | 44.80 | 0.471 times |
20 Wed Nov 2024 | 45.76 | 44.57 | 46.20 | 44.10 | 0.68 times |
19 Tue Nov 2024 | 44.81 | 43.81 | 45.30 | 42.65 | 1.368 times |
18 Mon Nov 2024 | 42.57 | 45.66 | 45.71 | 42.01 | 1.989 times |
15 Fri Nov 2024 | 45.65 | 48.81 | 49.64 | 45.63 | 2.623 times |
14 Thu Nov 2024 | 53.96 | 58.25 | 59.80 | 53.84 | 1.167 times |
13 Wed Nov 2024 | 58.61 | 59.79 | 60.37 | 58.46 | 0.301 times |
12 Tue Nov 2024 | 59.61 | 61.08 | 62.02 | 59.24 | 0.548 times |
11 Mon Nov 2024 | 61.09 | 61.13 | 62.13 | 60.55 | 0.533 times |
08 Fri Nov 2024 | 60.98 | 59.65 | 61.19 | 59.14 | 0.405 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 47.1, but if it comes above 47.1, then a intra day buy could be more profitable.
If you take a sell trade below 47.1, then use 47.1 as stoploss and 39.7 as target. However if you take a buy trade in stock , then use 47.1 as stoploss and 53.24 as target.
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 42.01 |
Downside Target | 45.63 |
Upside Target | 48.84 |
Upside Target | 52.77 |
Upside Target | 55.43 |
Upside Target | 56.82 |
Upside Target | 57.62 |
Upside Target | 61.49 |
Upside Target | 62.00 |
Upside Target | 62.13 |
Upside Target | 64.18 |
Upside Target | 65.53 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 43.07 |
Downside Intraday Target | 40.45 |
Upside Intraday Target | 47.26 |
Upside Intraday Target | 48.83 |
Downside Intraday Target | 44.64 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Thu Nov 2024 | 45.70 | 45.66 | 46.20 | 42.01 | 0.872 times |
15 Fri Nov 2024 | 45.65 | 61.13 | 62.13 | 45.63 | 2.046 times |
08 Fri Nov 2024 | 60.98 | 56.82 | 61.49 | 56.82 | 0.898 times |
01 Fri Nov 2024 | 57.15 | 49.72 | 57.62 | 49.71 | 1.543 times |
25 Fri Oct 2024 | 49.25 | 52.60 | 52.77 | 48.84 | 1.07 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Thu Nov 2024 | 45.70 | 55.66 | 62.13 | 42.01 | 1.205 times |
31 Thu Oct 2024 | 50.57 | 56.97 | 62.00 | 48.84 | 1.161 times |
30 Mon Sep 2024 | 57.24 | 63.59 | 64.18 | 55.43 | 0.887 times |
30 Fri Aug 2024 | 63.85 | 55.52 | 65.53 | 51.46 | 1.083 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Halozyme Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.48 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Halozyme Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.48 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.